Topic: Imexpharm

Imexpharm supports Da Lat’s tree-planting initiative, reinforcing its commitment to environmental sustainability and community well-being.

The long-term growth prospects of Vietnamese pharmaceutical companies are on the rise as they establish their position in the high-tech product segment, competing in both domestic and international markets.

Award comes in recognition of its commitment to employee growth.

With a team of leading talent in the pharmaceutical industry, Imexpharm is driving significant growth by boosting R&D as a strategy to develop high-tech pharmaceuticals.

The Imexpharm Pharmaceutical Joint Stock Company is committed to significantly investing in sustainable development as a strategic path to drive its future expansion into the global market.

The Imexpharm Pharmaceutical Joint Stock Company has been listed in the Top 50 Corporate Sustainability Awards 2023 held by the Nhip Cau Dau Tu - The BusinessReview magazine.

Beyond its position as a quality leader with the largest EU-GMP compliant manufacturing network in Vietnam, Imexpharm is also a pioneer among Vietnamese pharmaceutical companies in embracing digital transformation, unlocking new opportunities for expansion into major markets.

With record profit growth, the company is the Number 1 supplier of antibiotics in Vietnam and Number 5 in the market overall.

Local pharmaceutical companies prioritize affordably producing quality medications to develop a high-value industry, aiming to ease financial burdens on patients and ensure healthcare accessibility.

Leading Pharmaceutical Company, Imexpharm, Demonstrates Commitment to Environmental Stewardship Through Tree Planting Initiative